ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients

Bibliographic Details
Main Authors:	Ahmed Daoud, Hatem Ali, Vinaya Rao, Vinayak Rohan, Karim Soliman
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	Renal Failure
Online Access:	http://dx.doi.org/10.1080/0886022X.2021.1994419

Similar Items

Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01)

Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
by: Dorcas Beaton, et al.
Published: (2023-11-01)

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
by: Ivan T. Lee, et al.
Published: (2020-10-01)

Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
by: Trefor Morgan
Published: (2001-03-01)

Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
by: J. Spinar, et al.
Published: (2009-08-01)

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
by: John Matsoukas, et al.
Published: (2021-01-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2022-12-01)

Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function
by: Bo-qing Zhu, et al.
Published: (2003-03-01)

ACE inhibitors, angiotensin receptor antagonists and bradykinin
by: Michael Schachter
Published: (2000-03-01)

Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function?
by: Cody Carson, et al.
Published: (2016-01-01)

ACE-I and ARBs in early diabetic nephropathy
by: Michael Mauer, et al.
Published: (2002-12-01)

Current evidence on the combination of a direct renin inhibitor and an ARB or ACE inhibitor
by: Javier Díez
Published: (2010-12-01)

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ
by: Duprez D, et al.
Published: (2011-11-01)

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
by: Gian Paolo Rossi, et al.
Published: (2020-04-01)

RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
by: Ibrahim F. Benter, et al.
Published: (2013-01-01)

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
by: McMurray, J, et al.
Published: (2005)

Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
by: Geert Byttebier, et al.
Published: (2021-09-01)

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
by: Philip Braude, et al.
Published: (2020-12-01)

COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury
by: José Manuel González-Rayas, et al.
Published: (2020-05-01)

[Prevention with angiotensin-converting enzyme (ACE) inhibitors]
by: Ertl, G, et al.
Published: (1992)

Prevention with angiotensin-converting enzyme (ACE) inhibitors
by: Ertl, G, et al.
Published: (1992)

Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes
by: Carina M. Mathey, et al.
Published: (2022-07-01)

Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study
by: Michael H. Chiu, et al.
Published: (2018-10-01)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
by: Sandeep Bansal, et al.
Published: (2020-05-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
by: Hippisley-Cox, J, et al.
Published: (2020)

URTICARIAL ADVERSE DRUG REACTIONS TO ACE INHIBITORS AND BETA-BLOCKERS
by: T. Gancheva, et al.
Published: (2023-03-01)

The Use of ACE inhibitor/ARB in SARS-CoV-2 Patients: A Comprehensive Narrative Review
by: Timotius Ivan Hariyanto, et al.
Published: (2020-11-01)

Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
by: Chih-Ching Lin, et al.
Published: (2017-01-01)

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
by: Sieńko J, et al.
Published: (2020-07-01)

Comparison of Angiotensin-Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) for Heart Failure Treatment in Congenital Heart Diseases with Left-to-Right Shunt
by: Alit Utamayasa, et al.
Published: (2020-03-01)

Hospitalisations Related to the Combination of ACE Inhibitors and/or Angiotensin Receptor Blockers with Diuretics and NSAIDs: A Post Hoc Analysis on the Risks Associated with Triple Whammy
by: Irene Mattioli, et al.
Published: (2023-01-01)

Evaluation of angiotensin ii receptor blockers (ARBS) for drug formulary using objective scoring analytical tool.
by: Lim, Ming Tsuey
Published: (2011)

Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling.
by: Nicola E Clarke, et al.
Published: (2012-01-01)

Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-AnalysisPlain-Language Summary
by: Kirk N. Campbell, et al.
Published: (2022-05-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses
by: Julián Segura, et al.
Published: (2003-03-01)

Amadori compounds as potent inhibitors of angiotensin-converting enzyme (ACE) and their effects on anti-ACE activity of bell peppers
by: Jiahao Yu, et al.
Published: (2016-12-01)

Angiotensin-converting enzyme (ACE) I/D and bradykinin B2 receptor T/C genes polymorphism in patients with ACE inhibitors-related cough
by: Mohammad Saifur Rohman, et al.
Published: (2018-10-01)

Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
by: Andrea Kuenzli, et al.
Published: (2010-04-01)